GSK logo

GSK plc (GSK) return on equity

annual ROE:

23.06%-23.31%(-50.27%)
December 31, 2024

Summary

  • As of today (August 20, 2025), GSK annual return on equity is 23.06%, with the most recent change of -23.31% (-50.27%) on December 31, 2024.
  • During the last 3 years, GSK annual ROE has risen by +6.20% (+36.77%).
  • GSK annual ROE is now -90.95% below its all-time high of 254.91%, reached on December 31, 1996.

Performance

1-year change

-50.27%

3-year change

+36.77%

5-year change

-50.26%

15-year change

-55.21%

GSK ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

86.57%
GSK annual return on equity is higher than 86.57% of companies in Healthcare sector

Range

All-time high

254.91%
GSK annual return on equity is currently -90.95% below its historical high of 254.91%

3-year low

16.86%
GSK annual return on equity is currently +36.77% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
GSK previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
GSK next annual earnings announcement has not yet been scheduled

OtherGSKprofitability metrics

Annual revenue

$40.09B
GSK annual revenue is $40.09 billion

annual net income

$3.77B
GSK annual net profit is $3.77 billion

Annual EPS

$1.62
GSK annual earnings per share is $1.62

Annual ROA

5.04%
GSK annual return on assets is 5.04%

quarterly ROE:

28.93%+2.22%(+8.31%)
June 30, 2025

Summary

  • As of today (August 20, 2025), GSK quarterly return on equity is 28.93%, with the most recent change of +2.22% (+8.31%) on June 30, 2025.
  • Over the past year, GSK quarterly ROE has dropped by -4.60% (-13.72%).
  • GSK quarterly ROE is now -88.65% below its all-time high of 254.79%, reached on September 30, 1995.

Performance

3-month change

+8.31%

1-year change

-13.72%

3-year change

+43.86%

5-year change

-37.3%

GSK quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

87.3%
GSK quarterly return on equity is higher than 87.3% of companies in Healthcare sector

Range

All-time high

254.79%
GSK quarterly return on equity is currently -88.65% below its historical high of 254.79%

3-year low

20.11%
GSK quarterly return on equity is currently +43.86% above its 3-year low

Earnings dates

Last quarterly earnings report date

Jun 30, 2025
GSK previous earnings announcement was published on Jun 30, 2025

Next quarterly earnings report date

Oct 29, 2025
GSK next earnings announcement is scheduled for Oct 29, 2025

OtherGSKprofitability metrics

Quarterly revenue

$10.67B
GSK quarterly revenue is $10.67 billion

quarterly net income

$2.20B
GSK quarterly net profit is $2.20 billion

Quarterly EPS

$0.95
GSK quarterly earnings per share is $0.95

Quarterly ROA

6.69%
GSK quarterly return on assets is 6.69%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

annual ROE

23.06%
GSK annual return on equity is 23.06%

annual net income

$3.77B
GSK annual net profit is $3.77 billion

annual shareholders equity

$17.12B
GSK annual stockholders equity is $17.12 billion

GSK ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-50.3%-13.7%
3 y3 years+36.8%+43.9%
5 y5 years-50.3%-37.3%

GSK ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-50.3%+36.8%-51.8%+43.9%
5 y5-year-50.3%+36.8%-51.8%+56.3%
alltimeall time-91.0%+55.1%-88.7%+2233.1%

GSK ROE History

DateAnnualQuarterly
Jun 2025
-
28.93%(+8.3%)
Mar 2025
-
26.71%(+21.1%)
Dec 2024
23.06%(-50.3%)
22.05%(+2.9%)
Sep 2024
-
21.43%(-36.1%)
Jun 2024
-
33.53%(-12.8%)
Mar 2024
-
38.46%(-14.6%)
Dec 2023
46.37%(+57.0%)
45.03%(-25.0%)
Sep 2023
-
60.05%(+35.5%)
Jun 2023
-
44.33%(+18.4%)
Mar 2023
-
37.44%(+11.8%)
Dec 2022
29.53%(+75.1%)
33.49%(+52.0%)
Sep 2022
-
22.04%(+9.6%)
Jun 2022
-
20.11%(-12.9%)
Mar 2022
-
23.10%(+24.8%)
Dec 2021
16.86%(-45.7%)
18.51%(-10.5%)
Sep 2021
-
20.69%(-11.2%)
Jun 2021
-
23.31%(-19.1%)
Mar 2021
-
28.83%(-8.3%)
Dec 2020
31.05%(-33.0%)
31.45%(-13.7%)
Sep 2020
-
36.46%(-21.0%)
Jun 2020
-
46.14%(-2.8%)
Mar 2020
-
47.46%(-15.8%)
Dec 2019
46.36%(-59.6%)
56.37%(-29.8%)
Sep 2019
-
80.34%(-44.5%)
Jun 2019
-
144.64%(+19.2%)
Mar 2019
-
121.37%(+5.7%)
Dec 2018
114.83%(+123.1%)
114.80%(+80.5%)
Sep 2018
-
63.61%(+8.5%)
Jun 2018
-
58.63%(+48.4%)
Mar 2018
-
39.51%(-13.5%)
Dec 2017
51.48%(+246.2%)
45.70%(-22.9%)
Sep 2017
-
59.29%(+19.1%)
Jun 2017
-
49.77%(+40.2%)
Mar 2017
-
35.51%(+107.1%)
Dec 2016
14.87%(-87.9%)
17.15%(+421.3%)
Sep 2016
-
3.29%(+165.3%)
Jun 2016
-
1.24%(-83.0%)
Mar 2016
-
7.29%(-92.1%)
Dec 2015
123.10%(+172.5%)
92.52%(-19.9%)
Sep 2015
-
115.47%(-1.4%)
Jun 2015
-
117.14%(-12.8%)
Mar 2015
-
134.33%(+212.6%)
Dec 2014
45.18%(-38.8%)
42.97%(-30.7%)
Sep 2014
-
62.01%(-8.9%)
Jun 2014
-
68.07%(-5.8%)
Mar 2014
-
72.26%(-6.8%)
Dec 2013
73.79%(+22.8%)
77.55%(+40.9%)
Sep 2013
-
55.05%(-2.5%)
Jun 2013
-
56.49%(+1.2%)
Mar 2013
-
55.81%(-4.3%)
Dec 2012
60.10%(-0.5%)
58.34%(-6.0%)
Sep 2012
-
62.04%(+0.2%)
Jun 2012
-
61.94%(+7.7%)
Mar 2012
-
57.53%(-4.4%)
Dec 2011
60.39%(+244.3%)
60.16%(+59.1%)
Sep 2011
-
37.82%(+6.1%)
Jun 2011
-
35.64%(+73.7%)
Mar 2011
-
20.52%(+15.3%)
Dec 2010
17.54%(-71.1%)
17.79%(-56.3%)
Sep 2010
-
40.72%(-6.5%)
Jun 2010
-
43.55%(-30.5%)
Mar 2010
-
62.62%(-2.1%)
Dec 2009
60.72%(+10.9%)
63.97%(+9.4%)
Sep 2009
-
58.49%(+3.7%)
Jun 2009
-
56.43%(+3.7%)
Mar 2009
-
54.40%(-1.6%)
Dec 2008
54.74%(-0.6%)
55.29%(+3.4%)
Sep 2008
-
53.46%(+1.3%)
Jun 2008
-
52.79%(+3.8%)
Mar 2008
-
50.88%(-2.7%)
Dec 2007
55.05%(-13.3%)
52.31%(-3.1%)
Sep 2007
-
53.99%(-3.6%)
Jun 2007
-
56.01%(-4.6%)
Mar 2007
-
58.68%(-4.9%)
Dec 2006
63.50%
61.73%(-4.3%)
Sep 2006
-
64.50%(-2.7%)
Jun 2006
-
66.32%(-5.8%)
DateAnnualQuarterly
Mar 2006
-
70.37%(-2.7%)
Dec 2005
71.75%(+5.1%)
72.32%(+0.0%)
Sep 2005
-
72.31%(-3.6%)
Jun 2005
-
75.01%(-4.8%)
Mar 2005
-
78.78%(+3.3%)
Dec 2004
68.25%(-20.2%)
76.23%(-1.3%)
Sep 2004
-
77.26%(+9.1%)
Jun 2004
-
70.81%(+4.9%)
Mar 2004
-
67.52%(-2.0%)
Dec 2003
85.54%(+7.6%)
68.92%(+0.5%)
Sep 2003
-
68.55%(+12.4%)
Jun 2003
-
60.98%(+2.2%)
Mar 2003
-
59.64%(-1.7%)
Dec 2002
79.52%(+54.3%)
60.67%(+14.1%)
Sep 2002
-
53.19%(+16.3%)
Jun 2002
-
45.75%(+7.0%)
Mar 2002
-
42.75%(+9.9%)
Dec 2001
51.53%(-28.6%)
38.89%(-10.2%)
Sep 2001
-
43.30%(-12.2%)
Jun 2001
-
49.32%(-0.4%)
Mar 2001
-
49.54%(-15.4%)
Dec 2000
72.21%(-5.1%)
58.56%(+17.9%)
Sep 2000
-
49.69%(-8.8%)
Jun 2000
-
54.46%(-7.1%)
Mar 2000
-
58.60%(-15.0%)
Dec 1999
76.11%(-5.0%)
68.94%(+4.8%)
Sep 1999
-
65.77%(-22.9%)
Jun 1999
-
85.26%(+12.6%)
Mar 1999
-
75.70%(-27.3%)
Dec 1998
80.08%(-31.3%)
104.10%(+25.2%)
Sep 1998
-
83.18%(+11.8%)
Jun 1998
-
74.37%(-19.7%)
Mar 1998
-
92.62%(+30.8%)
Dec 1997
116.64%(-54.2%)
70.79%(-60.7%)
Sep 1997
-
180.15%(+15.3%)
Jun 1997
-
156.25%(+1.3%)
Mar 1997
-
154.23%(+142.4%)
Dec 1996
254.91%(+560.4%)
63.62%(-74.8%)
Mar 1996
-
252.77%(-0.8%)
Dec 1995
38.60%(+46.7%)
-
Sep 1995
-
254.79%(+761.7%)
Jun 1995
-
29.57%(+40.5%)
Mar 1995
-
21.05%(-3.9%)
Dec 1994
-
21.91%(-6.5%)
Sep 1994
-
23.44%(-22.5%)
Jun 1994
26.32%(-6.4%)
30.24%(+7.3%)
Mar 1994
-
28.19%(-2.8%)
Dec 1993
-
28.99%(+3.9%)
Sep 1993
-
27.89%(-16.7%)
Jun 1993
28.11%(-5.9%)
33.48%(+26.2%)
Mar 1993
-
26.53%(+1.5%)
Dec 1992
-
26.13%(-0.2%)
Sep 1992
-
26.19%(-29.7%)
Jun 1992
29.88%(-6.7%)
37.28%(+0.8%)
Mar 1992
-
37.00%(+5.1%)
Dec 1991
-
35.21%(+5.4%)
Sep 1991
-
33.42%(-21.3%)
Jun 1991
32.01%(+3.3%)
42.49%(+36.4%)
Mar 1991
-
31.14%(+3.0%)
Dec 1990
-
30.23%(+3.2%)
Sep 1990
-
29.30%(-32.5%)
Jun 1990
31.00%(-12.5%)
43.43%(+14.1%)
Mar 1990
-
38.07%(+8.6%)
Dec 1989
-
35.07%(+3.7%)
Sep 1989
-
33.83%(-22.1%)
Jun 1989
35.43%(-5.4%)
43.41%(+14.5%)
Mar 1989
-
37.91%(+2.7%)
Dec 1988
-
36.93%(+4.3%)
Sep 1988
-
35.40%(-19.4%)
Jun 1988
37.47%(-2.7%)
43.94%(+8.3%)
Mar 1988
-
40.57%(+1.5%)
Dec 1987
-
39.99%(+7.6%)
Sep 1987
-
37.18%(+8.6%)
Jun 1987
38.50%(-8.0%)
34.25%(-18.5%)
Mar 1987
-
42.03%(+9.6%)
Dec 1986
-
38.34%(+3.1%)
Sep 1986
-
37.20%(+5.5%)
Jun 1986
41.85%
35.27%

FAQ

  • What is GSK plc annual return on equity?
  • What is the all time high annual ROE for GSK plc?
  • What is GSK plc annual ROE year-on-year change?
  • What is GSK plc quarterly return on equity?
  • What is the all time high quarterly ROE for GSK plc?
  • What is GSK plc quarterly ROE year-on-year change?

What is GSK plc annual return on equity?

The current annual ROE of GSK is 23.06%

What is the all time high annual ROE for GSK plc?

GSK plc all-time high annual return on equity is 254.91%

What is GSK plc annual ROE year-on-year change?

Over the past year, GSK annual return on equity has changed by -23.31% (-50.27%)

What is GSK plc quarterly return on equity?

The current quarterly ROE of GSK is 28.93%

What is the all time high quarterly ROE for GSK plc?

GSK plc all-time high quarterly return on equity is 254.79%

What is GSK plc quarterly ROE year-on-year change?

Over the past year, GSK quarterly return on equity has changed by -4.60% (-13.72%)
On this page